CytoSorbents Corporation (CTSO)

[vinovista]

"While CytoSorb demand is likely to remain strong in the second quarter, we think the demand would likely weaken, extending through the rest of 2020, as the pandemic subsides resulting in lower revenues during this time. However, if there is a second and third resurgence from this virus, we could witness demand shooting up again for CytoSorb."
When was this statement made? If I remember it was a few weeks ago when we started to bend down. We are in the last week bending UP. Glad to see they have expansion at least on the table.
That was a good call on the first expansion agreed.